1 |
anti-beta2-glycoprotein I
(72 times)
|
Rheumatology (21 times)
|
aCL (55 times) APS (45 times) aPL (37 times)
|
1997 Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.
|
2 |
anti-beta2 glycoprotein I antibodies
(38 times)
|
Vascular Diseases (9 times)
|
aCL (29 times) aPL (23 times) APS (22 times)
|
1999 Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: effects of Tween 20 and relationship with antibodies to beta2-glycoprotein I.
|
3 |
anti-beta2GPI antibodies
(5 times)
|
Rheumatology (2 times)
|
APS (4 times) beta2GPI (3 times) aCL (2 times)
|
2010 [Laboratory examinations in antiphospholipid syndrome].
|
4 |
anti-beta2GPI
(4 times)
|
Rheumatology (2 times)
|
aCL (4 times) APS (2 times) SLE (2 times)
|
2000 Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.
|
5 |
anti-human beta2-Glycoprotein I
(3 times)
|
Vascular Diseases (3 times)
|
aCL (3 times) APS (3 times) LA (3 times)
|
2005 Antibody profiles for the diagnosis of antiphospholipid syndrome.
|
6 |
antibodies to beta2-glycoprotein I
(2 times)
|
Internal Medicine (1 time)
|
aPLs (1 time) APS (1 time) DFPP (1 time)
|
2002 Antiphospholipid syndrome treated with prednisolone, cyclophosphamide and double-filtration plasmapheresis.
|
7 |
antibodies against beta2-glycoprotein I
(1 time)
|
Rheumatology (1 time)
|
aCL (1 time) aPLs (1 time) IgAV (1 time)
|
2018 Antiphospholipid antibodies in adult IgA vasculitis: observational study.
|
8 |
antibodies against beta2GPI
(1 time)
|
Rheumatology (1 time)
|
ANXA5 (1 time) beta2GPI (1 time) GPVs (1 time)
|
2006 Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-beta2-glycoprotein I and anti-annexin A5 antibodies.
|
9 |
antibodies directed to beta2-Glycoprotein I
(1 time)
|
Vascular Diseases (1 time)
|
---
|
2018 Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns.
|